Patients with FX levels <10 % present with mucocutaneous bleeding, whereas those with moderate to severe deficiency may have symptoms such as hemarthrosis, intracranial hemorrhage, and gastrointestinal bleeding. Here, F10 is linked to intracranial hemorrhage.